Sms Pharmaceuticals (SMSPHARMA) — base & breakout chart

Healthcare · Pharmaceuticals & BiotechnologyStock page

Where it stands

Stage
Climbing
Pivot
₹447.80
Price
₹462.15
RS
78
+3.2% through±25%
Sessions since 10Turnover ₹6.9 Cras of 28 Sept 2026

Trend

  • Above 50-day: yes
  • Above 150-day: yes
  • Above 200-day: yes
  • 150-day over 200-day: yes
  • Trend template met: yes
Bulk/block deals: 1 buy / 1 sellInsiders net sellers (1 buy / 3 sell)

Price chart with bases

9th base on record. The latest cleared its ₹447.80 pivot on 11 Sept 2026.

Price chart of SMSPHARMA, 493 daily bars from 2024-09-30 to 2026-09-28, with 1 bases shaded. Every base is listed in the table below.

Base history

Every base the detector recorded for this stock, newest first. Select one to highlight it on the chart.

BaseFormedBase ageDepthPivotContractionsSquats / pokesOutcome
15 Apr 2026 – 10 Sept 202621w22.0%₹447.803(last 9.0%)0 / 0Broke out11 Sept 2026 on 28.0× volVCP · High since 2020

Showing the latest of 9 bases on record. The 8 earlier ones are drawn on the chart and listed here with Pro.

You were looking for stocks building a base.See every setup

What this chart shows

Sms Pharmaceuticals (SMSPHARMA) broke out of its latest base on 11 Sep 2026 (10 trading sessions ago) and is still trading above that base's ceiling. That base ran from 15 Apr 2026 to 10 Sep 2026, about 21 weeks. Its ceiling — the highest price inside the base, which traders call the pivot — was ₹447.80. On the breakout day it closed at ₹463.45, on trading volume 28.0 times its average daily volume during the base. The last close on 28 Sep 2026 was ₹462.15, 3.2% above the ceiling. From its highest point to its lowest, the base is 22.0% deep. Inside it the price has pulled back three times, each pullback shallower than the one before. The ceiling is also the highest price SMSPHARMA has reached since 2020, which is as far back as our price history goes. In our four-stage lifecycle it is currently "climbing": broke out earlier and is still trading above its ceiling.

Its relative strength reading is 78 out of 99. That means its price over the past year has done better than about 78% of the 940 stocks we rank. It is a comparison with other stocks, not a forecast. Among the 71 Pharmaceuticals & Biotechnology stocks we track, it ranks 23 of 71 by that reading. The last close is above its 50-day, 150-day and 200-day averages — the average closing price over the last 50, 150 and 200 trading sessions, which people use to judge the longer trend. The 150-day average is itself above the 200-day average.

Since our base records begin (April 2024), we have found nine bases in SMSPHARMA. All nine broke out above their ceilings. Today's price is above the breakout-day close of 8 of those 9 breakouts.

How to read this page: a base is a stretch of weeks or months in which a stock stops trending and moves sideways within a range. The top of that range is its ceiling, which traders call the pivot; a close above it is what we count as a breakout. Relative strength compares a stock's price performance over the past year with every other stock we track, on a scale of 1 to 99. All of this describes what the price has already done. It is not a recommendation to buy or sell, and it does not predict what the price will do next. Our price history begins in 2020, so any "high" on this page means the highest price since 2020.

How to read it

  • Shaded box — a base: the stretch where the stock stopped trending and traded sideways, from its high (the pivot) down to its lowest low.
  • Line at the top of the box — the pivot, the price a close has to clear for the base to resolve upward. It runs on to the breakout, or to today for a base still forming.
  • Arrow under a candle — the breakout day, with that day's volume as a multiple of the base's own average.
  • P and S — a failed poke (traded above the pivot but closed back under it) and a squat (closed just under the pivot on light volume).

Prices are adjusted for splits and bonuses. Our price history starts in 2020, so any high mentioned here is a high since 2020, not an all-time high. Base detection describes past price and volume; it is for research and education, is not investment advice, and no pattern predicts future returns.

Sms Pharmaceuticals (SMSPHARMA) Base & Breakout Chart | DocStoX